Scalper1 News
Shareholders of Perrigo (PRGO) rejected a hostile takeover bid by fellow generic drug maker Mylan (MYL) Friday morning, sending Perrigo stock down and Mylan up in early trading. Mylan said in a press release that by the 8 a.m. ET deadline some 40% of Perrigo shares had been validly tendered, missing the 50% required for the takeover to succeed. Mylan management maintained in the statement that it would be fine without Perrigo. “Mylan’s focused Scalper1 News
Scalper1 News